Scientists identify risk factors for glioma subtypes
Researchers conducted the largest malignant brain tumor study to date, finding genetic markers of glioma, a highly aggressive form of brain cancer.
By Amy Wallace
Researchers have identified genetic markers for two subtypes of glioblastoma, a highly aggressive form of brain cancer. Photo by sfam_photo/Shutterstock
March 27 (UPI) -- A team of international researchers led by scientists at Baylor College of Medicine in Houston have identified genetic markers for two subtypes of glioma, an aggressive form of brain cancer.
Nearly 24,000 people will be diagnosed with malignant brain tumors in 2017, and 17,000 will die from them. The most common and deadly form of brain cancer is glioblastoma, which has a five-year survival rate of less than 6 percent.
For the study, researchers analyzed millions of genetic variants using genome-wide association analysis to scan for markers on complete genomes from nearly 12,500 patients with glioma and 18,000 healthy individuals.
"Until now our understanding of the risks of developing glioma has been limited," Dr. Melissa Bondy, professor of medicine, associate director of population sciences at the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, said in a press release. "In this work we confirmed 13 previously identified markers and uncovered 13 new genetic markers associated with this aggressive disease. We now have a more comprehensive genetic profile of the disease spectrum that expands our understanding of glioma susceptibility."
RELATED Scientists use tumor-seeking salmonella to treat brain tumors in rats
The genetic markers identified in the study were linked to higher susceptibility for developing brain tumors, however, each genetic marker gave just a modest increase in risk, according to researchers.
"This work has revealed a set of genetic factors that are involved in glioma development," said Dr. Beatrice Melin, professor and head of the Regional Cancer Center North at Umea University in Sweden. "Understanding how glioma develops opens the possibility for developing better surveillance, diagnostics and treatment."
The study was published in Nature Genetics.
RELATED Combination immunotherapy kills brain cancer in mice: Study
RELATED Doctors use malaria drug to successfully treat brain cancer patient
Health News // 14 hours ago
Parents struggling with infant feeding issues may have another reason to persevere: New research ties feeding problems with an increased risk of developmental delays.
Health News // 3 days ago
Study: Cancer patients given high-dose radiation treatments even near end of life
Jan. 14 (UPI) -- Many older cancer patients whose disease has spread to other parts of the body continue to receive high-dose radiation therapy, despite guidelines that recommend against its use, a JAMA Health Forum analysis found.
Study confirms risks of COVID-19 in pregnancy for unvaccinated mothers, babies
Unvaccinated pregnant women are putting themselves and their baby at risk for serious complications of COVID-19, according to new research out of Scotland.
Starting hormone therapy in teens may improve mental health for transgender people
Transgender people get greater mental health benefits if they start gender-affirming hormone treatment when they're teens instead of waiting until they're adults, a new study finds.
Face masks may make men more attractive, study suggests
Welsh researchers found that masking up may make men look more attractive to the opposite sex and that some kinds of masks do a better job of this than others.
Study finds 1 in 10 people with COVID-19 remains infectious beyond 10 days
One in 10 people with COVID-19 still could be infectious beyond 10 days, and some could remain so for as long as two months, a new study suggests.
Jan. 14 (UPI) -- Talking about politics makes people in the United States sick, literally, a study published Friday by the journal PLOS ONE found.
COVID-19's silver lining: speeding vaccine tech for other diseases
NEW YORK, Jan. 14 (UPI) -- Scientists have been working with mRNA technology for more than two decades, and many believe that it can produce vaccines against cancer, malaria, heart disease, HIV and other diseases.
Monoclonal antibody for arthritis in cats receives FDA approval
Arthritis can keep a cat from doing many of the things that kitties love to do. But now there's hope: The first treatment to ease arthritis pain in cats has been approved by the U.S. Food and Drug Administration.
Social media posts by celebrities often promote junk food
Images of people eating and drinking are a staple of social media, but new research finds such posts from celebrities often puts the spotlight squarely on junk food.
Less than a tablespoon of olive oil a day slows death risk, study says
Massachusetts menthol ban brings drop in cigarette sales, study finds